You just read:

Boehringer Ingelheim to Present 14 Abstracts at the Annual American Thoracic Society International Conference Including Phase 3 Data on Investigational Therapy Nintedanib

News provided by

Boehringer Ingelheim Pharmaceuticals, Inc.

Apr 30, 2014, 10:15 ET